Japan Eyewear Holdings (5889) · RiskRestated
Regulatory Risk under the Medical Practitioners' Act Concerning Assistance in Measuring Eyeglass Prescriptions
First written in FY2024. 1 of 2 entries say "Restated". Latest entry: FY2026.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Response to Medical Practitioners' Act Regulations Concerning Prescription-Strength MeasurementsA theme 3 companies write about · 3 as a headwind · 0 as a tailwind
1 other company's latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2026RestatedAnnual report
「Our group believes that even such assistance requires sufficient technical skills and knowledge, and is focusing on enhancing its internal training programs.」
The uncertainty under the Medical Practitioners' Act regarding assistance with prescription measurements is disclosed, with enhanced internal training programs reiterated as a countermeasure. - FY2024First statedAnnual report
「If, as a result of amendments to laws and regulations or changes in their interpretation, assistance with prescription measurements as described above were determined to constitute medical practice, this could affect the operating results and financial condition of our group due to a decline in net sales accompanying a change in the business model or for other reasons.」
The possibility that assistance with prescription measurements when selling eyeglasses could be deemed medical practice following amendments to laws and regulations or changes in their interpretation is identified.